FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

35846311000001108: Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Oct 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
110153901000001113 Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110154001000001111 Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Is a Oxycodone 10mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has AMP Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has excipient Lactose false Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Oxypro 10mg modified-release tablets (Ridge Pharma Ltd) 56 tablet 4 x 14 tablets VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start